Listening to you

Listening to you

It’s really important to GAIN to hear from our members, our supporters, our fundraisers, our volunteers, and anyone else who cares about GBS, CIDP, and what we do.  That’s why we are carrying out a listening exercise to understand what you think about GAIN, what we...
Budget 2024

Budget 2024

Budget 2024  With this being the last budget before an election, we may have been expecting a few more crowd-pleasing policies and vote winning announcements. In terms of people impacted by GBS, CIDP, and other autoimmune conditions, and for GAIN itself, to be honest,...
We have a new CEO

We have a new CEO

Monday 22nd January 2024 GAIN have appointed Rich Collins to the role of CEO. Rich’s background is in community sector leadership, strategy, and social policy. He has previously been a Chief Executive in a not for profit organisation, but also has significant...
Treatment Approaches for Atypical CIDP

Treatment Approaches for Atypical CIDP

The variants of chronic inflammatory demyelinating polyneuropathy (CIDP) differ not just in their clinical, pathological and electrophysiological characteristics, but often in their indifferent response to conventional immunosuppressive agents which are effective in...